跳至主要内容
临床试验/ITMCTR2200006708
ITMCTR2200006708尚未招募未知

A single-center, randomized, controlled study of the combination of tonifying the kidneys, relieving dampness and resolving blood stasis formula with weight loss in the treatment of obese polycystic ovary syndrome with insulin resistance

Shenzhen Traditional Chinese Medicine Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
20 至 40(—)
性别
Female

入选标准

  • 1. conform to Chinese or Western diagnosis of polycystic ovary syndrome with insulin resistance.
  • 2. Women aged 20-40 years with no pregnancy plan in the future 6 months.
  • 3. Body mass index (BMI) = weight/height^2 (kg/m^2) >= 24.
  • 4. Voluntary participation and signed informed consent.
  • 5. have the ability to use a smartphone to cooperate with medical weight loss online guidance and follow-up.
  • 6. If using hormonal medication, the medication should be stopped for more than 3 months.

排除标准

  • 1. Those who do not meet the inclusion criteria or do not take the drug as prescribed or have poor compliance.
  • 2. Patients who are participating in clinical trials of other drugs.
  • 3. Have recently taken hormonal drugs or other western drugs
  • 4. Have obvious organic lesions or malformations of the reproductive system, or serious systemic diseases such as cardiovascular, endocrine, liver, kidney and hematopoietic system and other important organ lesions and psychiatric patients, as confirmed by examination test measurements.

研究者

发起方
Shenzhen Traditional Chinese Medicine Hospital

相似试验